Literature DB >> 12933672

Intracerebroventricular galanin-like peptide induces different brain activation compared with galanin.

Catherine B Lawrence1, Torrie Williams, Simon M Luckman.   

Abstract

Like galanin, the 60-amino-acid peptide, galanin-like peptide (GALP), has orexigenic actions, demonstrated by an acute increase in feeding after central injection in rodents. However, in contrast to galanin, GALP causes a prolonged rise in core body temperature and a reduction in body weight over 24 h. In an attempt to identify potential explanations for the observed differences between GALP and galanin, this study examined which brain areas were activated by these peptides. Intracerebroventricular injection of GALP into conscious rats significantly stimulated feeding over 0-1 h, increased core body temperature, but reduced body weight gain over 24 h. Immunohistochemistry to detect c-fos demonstrated that intracerebroventricular injection of GALP or galanin activated several brain regions in common, including the dorsomedial nucleus of the hypothalamus, lateral hypothalamus, and nucleus tractus solitarius of the brainstem. However, GALP also induced c-fos expression in the periventricular hypothalamic region and supraoptic hypothalamic nucleus. Cell activation induced by GALP in the supraoptic hypothalamic nucleus and nucleus tractus solitarius was dependent on food intake but independent of food consumption in all other brain regions. Double immunohistochemistry indicated that small cells expressing c-fos in the periventricular hypothalamic region after GALP were astrocytes and not microglia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933672     DOI: 10.1210/en.2003-0391

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  Galanin: a potential role in mesolimbic dopamine-mediated instrumental behavior.

Authors:  John K Robinson; Ariel Brewer
Journal:  Neurosci Biobehav Rev       Date:  2008-06-03       Impact factor: 8.989

2.  Alarin stimulates food intake in male rats and LH secretion in castrated male rats.

Authors:  Nicole Van Der Kolk; Farrah N Madison; Margaret Mohr; Nicole Eberhard; Barbara Kofler; Gregory S Fraley
Journal:  Neuropeptides       Date:  2010-08       Impact factor: 3.286

3.  Alarin stimulates food intake and gonadotrophin release in male rats.

Authors:  C K Boughton; M Patterson; G A Bewick; J A Tadross; J V Gardiner; K E L Beale; F Chaudery; G Hunter; M Busbridge; E M Leavy; M A Ghatei; S R Bloom; K G Murphy
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 4.  Galanin-like peptide (GALP) is a hypothalamic regulator of energy homeostasis and reproduction.

Authors:  Catherine Lawrence; Gregory S Fraley
Journal:  Front Neuroendocrinol       Date:  2010-06-15       Impact factor: 8.606

5.  The Pivotal Role of Neuropeptide Crosstalk from Ventromedial-PACAP to Dorsomedial-Galanin in the Appetite Regulation in the Mouse Hypothalamus.

Authors:  Yuki Kambe; Thanh Trung Nguyen; Toshiharu Yasaka; Thu Thi Nguyen; Yoshimune Sameshima; Kohei Hashiguchi; Norihito Shintani; Hitoshi Hashimoto; Takashi Kurihara; Atsuro Miyata
Journal:  Mol Neurobiol       Date:  2022-10-17       Impact factor: 5.682

6.  Galanin-like peptide (GALP) facilitates thermogenesis via synthesis of prostaglandin E2 by astrocytes in the periventricular zone of the third ventricle.

Authors:  Haruaki Kageyama; Kei Endo; Toshimasa Osaka; Jun Watanabe; Li Hua Wang; Kazuo Ito; Mamiko Suzuki; Junichi Sakagami; Fumiko Takenoya; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2013-01-26       Impact factor: 3.444

7.  Interleukin-1 mediates the anorexic and febrile actions of galanin-like Peptide.

Authors:  Pui-Sin Man; Catherine B Lawrence
Journal:  Endocrinology       Date:  2008-07-10       Impact factor: 4.736

8.  The effects of galanin-like peptide on energy balance, body temperature and brain activity in the mouse and rat are independent of the GALR2/3 receptor.

Authors:  P-S Man; C B Lawrence
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.